{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:20:33Z","timestamp":1790176833055,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY018876"],"award-info":[{"award-number":["R01 EY018876"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Many retinal degenerative diseases are caused by the loss of retinal ganglion cells (RGCs). Autosomal dominant optic atrophy is the most common hereditary optic atrophy disease and is characterized by central vision loss and degeneration of RGCs. Currently, there is no effective treatment for this group of diseases. However, stem cell therapy holds great potential for replacing lost RGCs of patients. Compared with embryonic stem cells, induced pluripotent stem cells (iPSCs) can be derived from adult somatic cells, and they are associated with fewer ethical concerns and are less prone to immune rejection. In addition, patient-derived iPSCs may provide us with a cellular model for studying the pathogenesis and potential therapeutic agents for optic atrophy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, iPSCs were obtained from patients carrying an<jats:italic>OPA1<\/jats:italic>mutation (<jats:italic>OPA1<\/jats:italic><jats:sup><jats:italic>+\/\u2212<\/jats:italic><\/jats:sup><jats:italic>-<\/jats:italic>iPSC) that were diagnosed with optic atrophy. These iPSCs were differentiated into putative RGCs, which were subsequently characterized by using RGC-specific expression markers BRN3a and ISLET-1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mutant<jats:italic>OPA1<\/jats:italic><jats:sup><jats:italic>+\/\u2212<\/jats:italic><\/jats:sup>-iPSCs exhibited significantly more apoptosis and were unable to efficiently differentiate into RGCs. However, with the addition of neural induction medium, Noggin, or estrogen,<jats:italic>OPA1<\/jats:italic><jats:sup><jats:italic>+\/\u2212<\/jats:italic><\/jats:sup>-iPSC differentiation into RGCs was promoted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results suggest that apoptosis mediated by<jats:italic>OPA1<\/jats:italic>mutations plays an important role in the pathogenesis of optic atrophy, and both noggin and \u03b2-estrogen may represent potential therapeutic agents for<jats:italic>OPA1-<\/jats:italic>related optic atrophy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13287-015-0264-1","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T01:33:58Z","timestamp":1452130438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets"],"prefix":"10.1186","volume":"7","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Riazifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"264_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.20278","volume":"56","author":"R Lodi","year":"2004","unstructured":"Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, et al. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol. 2004;56:719\u201323.","journal-title":"Ann Neurol."},{"key":"264_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/brain\/awm335","volume":"131","author":"C Zanna","year":"2008","unstructured":"Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain. 2008;131:352\u201367.","journal-title":"Brain."},{"key":"264_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajo.2014.05.034","volume":"158","author":"P Barboni","year":"2014","unstructured":"Barboni P, Savini G, Cascavilla ML, Caporali L, Milesi J, Borrelli E, et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation. Am J Ophthalmol. 2014;158:628\u201336.","journal-title":"Am J Ophthalmol."},{"key":"264_CR4","doi-asserted-by":"publisher","first-page":"e17084","DOI":"10.1371\/journal.pone.0017084","volume":"6","author":"ZB Jin","year":"2011","unstructured":"Jin ZB, Okamoto S, Osakada F, Homma K, Assawachananont J, Hirami Y, et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One. 2011;6:e17084.","journal-title":"PLoS One."},{"key":"264_CR5","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/hmg\/ddq341","volume":"19","author":"JL Liao","year":"2010","unstructured":"Liao JL, Yu J, Huang K, Hu J, Diemer T, Ma Z, et al. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet. 2010;19:4229\u201338.","journal-title":"Hum Mol Genet."},{"key":"264_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/stem.674","volume":"29","author":"JS Meyer","year":"2011","unstructured":"Meyer JS, Howden SE, Wallace KA, Verhoeven AD, Wright LS, Capowski EE, et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells. 2011;29:1206\u201318.","journal-title":"Stem Cells."},{"key":"264_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ICU.0b013e328352407d","volume":"23","author":"MD Tibbetts","year":"2012","unstructured":"Tibbetts MD, Samuel MA, Chang TS, Ho AC. Stem cell therapy for retinal disease. Curr Opin Ophthalmol. 2012;23:226\u201334.","journal-title":"Curr Opin Ophthalmol."},{"key":"264_CR8","doi-asserted-by":"publisher","first-page":"e18992","DOI":"10.1371\/journal.pone.0018992","volume":"6","author":"BA Tucker","year":"2011","unstructured":"Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, et al. Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One. 2011;6:e18992.","journal-title":"PLoS One."},{"key":"264_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/stem.637","volume":"29","author":"L Zhou","year":"2011","unstructured":"Zhou L, Wang W, Liu Y, Fernandez de Castro J, Ezashi T, Telugu BP, et al. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells. 2011;29:972\u201380.","journal-title":"Stem Cells."},{"key":"264_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell."},{"key":"264_CR11","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320.","journal-title":"Science."},{"key":"264_CR12","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1242\/dev.01298","volume":"131","author":"JR Spence","year":"2004","unstructured":"Spence JR, Madhavan M, Ewing JD, Jones DK, Lehman BM, Del Rio-Tsonis K. The hedgehog pathway is a modulator of retina regeneration. Development. 2004;131:4607\u201321.","journal-title":"Development."},{"key":"264_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.mcn.2006.05.002","volume":"32","author":"C Yu","year":"2006","unstructured":"Yu C, Mazerolle CJ, Thurig S, Wang Y, Pacal M, Bremner R, et al. Direct and indirect effects of hedgehog pathway activation in the mammalian retina. Mol Cell Neurosci. 2006;32:274\u201382.","journal-title":"Mol Cell Neurosci."},{"key":"264_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000090759","volume":"28","author":"BR Nelson","year":"2006","unstructured":"Nelson BR, Gumuscu B, Hartman BH, Reh TA. Notch activity is downregulated just prior to retinal ganglion cell differentiation. Dev Neurosci. 2006;28:128\u201341.","journal-title":"Dev Neurosci."},{"key":"264_CR15","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/dvdy.21083","volume":"236","author":"TQ Crawford","year":"2007","unstructured":"Crawford TQ, Roelink H. The notch response inhibitor DAPT enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independently of sonic hedgehog signaling. Dev Dyn. 2007;236:886\u201392.","journal-title":"Dev Dyn."},{"key":"264_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5966\/sctm.2013-0147","volume":"3","author":"H Riazifar","year":"2014","unstructured":"Riazifar H, Jia Y, Chen J, Lynch G, Huang T. Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells. Stem Cells Transl Med. 2014;3:424\u201332.","journal-title":"Stem Cells Transl Med."},{"key":"264_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell."},{"key":"264_CR18","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1074\/jbc.C200677200","volume":"278","author":"A Olichon","year":"2003","unstructured":"Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003;278:7743\u20136.","journal-title":"J Biol Chem."},{"key":"264_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0022-1759(95)00172-7","volume":"185","author":"T Idziorek","year":"1995","unstructured":"Idziorek T, Estaquier J, De Bels F, Ameisen JC. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods. 1995;185:249\u201358.","journal-title":"J Immunol Methods."},{"key":"264_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/IAE.0b013e31817d8c1b","volume":"28","author":"RF Spaide","year":"2008","unstructured":"Spaide RF. The potential of pluripotent cells in vitreoretinal diseases. Retina. 2008;28:1031\u20134.","journal-title":"Retina."},{"key":"264_CR21","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicol\u00e1s","year":"2009","unstructured":"Nadal-Nicol\u00e1s FM, Jim\u00e9nez-L\u00f3pez M, Sobrado-Calvo P, Nieto-L\u00f3pez L, C\u00e1novas-Mart\u00ednez I, Salinas-Navarro M, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci. 2009;50:3860\u20138.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"264_CR22","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1242\/dev.010751","volume":"135","author":"L Pan","year":"2008","unstructured":"Pan L, Deng M, Xie X, Gan L, et al. ISL1 and BRN3B co-regulate the differentiation of murine retinal ganglion cells. Development. 2008;135:1981\u201390.","journal-title":"Development."},{"key":"264_CR23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218\u201321.","journal-title":"Science."},{"key":"264_CR24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/stem.511","volume":"28","author":"YH Kim","year":"2010","unstructured":"Kim YH, Chung JI, Woo HG, Jung YS, Lee SH, Moon CH, et al. Differential regulation of proliferation and differentiation in neural precursor cells by the Jak pathway. Stem Cells. 2010;28:1816\u201328.","journal-title":"Stem Cells."},{"key":"264_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.scr.2011.08.008","volume":"8","author":"H Salehi","year":"2012","unstructured":"Salehi H, Karbalaie K, Salamian A, Kiani A, Razavi S, Nasr-Esfahani MH, et al. Differentiation of human ES cell-derived neural progenitors to neuronal cells with regional specific identity by co-culturing of notochord and somite. Stem Cell Res. 2012;8:120\u201333.","journal-title":"Stem Cell Res."},{"key":"264_CR26","doi-asserted-by":"publisher","first-page":"e1000174","DOI":"10.1371\/journal.pbio.1000174","volume":"7","author":"AS Viczian","year":"2009","unstructured":"Viczian AS, Solessio EC, Lyou Y, Zuber ME. Generation of functional eyes from pluripotent cells. PLoS Biol. 2009;7:e1000174.","journal-title":"PLoS Biol."},{"key":"264_CR27","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/stem.167","volume":"27","author":"L Lan","year":"2009","unstructured":"Lan L, Vitobello A, Bertacchi M, Cremisi F, Vignali R, Andreazzoli M, et al. Noggin elicits retinal fate in Xenopus animal cap embryonic stem cells. Stem Cells. 2009;27:2146\u201352.","journal-title":"Stem Cells."},{"key":"264_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/stem.320","volume":"28","author":"S Parameswaran","year":"2010","unstructured":"Parameswaran S, Balasubramanian S, Babai N, Qiu F, Eudy JD, Thoreson WB, et al. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells. 2010;28:695\u2013703.","journal-title":"Stem Cells."},{"key":"264_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/brain\/awq276","volume":"134","author":"C Giordano","year":"2011","unstructured":"Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain. 2011;134:220\u201334.","journal-title":"Brain."},{"key":"264_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/eye.2011.2","volume":"25","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Bailie M, Atawan A, Chinnery PF, Griffiths PG. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye (Lond). 2011;25:596\u2013602.","journal-title":"Eye (Lond)"},{"key":"264_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/archopht.124.6.853","volume":"124","author":"RS Harwerth","year":"2006","unstructured":"Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol. 2006;124:853\u20139.","journal-title":"Arch Ophthalmol."},{"key":"264_CR32","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","volume":"4","author":"W Yarosh","year":"2008","unstructured":"Yarosh W, Monserrate J, Tong JJ, Tse S, Le PK, Nguyen K, et al. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet. 2008;4:e6.","journal-title":"PLoS Genet."},{"key":"264_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0079-6123(09)17502-7","volume":"175","author":"DA Lamba","year":"2009","unstructured":"Lamba DA, Karl MO, Reh TA. Strategies for retinal repair: cell replacement and regeneration. Prog Brain Res. 2009;175:23\u201331.","journal-title":"Prog Brain Res."},{"key":"264_CR34","doi-asserted-by":"publisher","first-page":"11331","DOI":"10.1073\/pnas.0500010102","volume":"102","author":"H Ikeda","year":"2005","unstructured":"Ikeda H, Osakada F, Watanabe K, Mizuseki K, Haraquchi T, Miyoshi H. Generation of Rx+\/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci U S A. 2005;102:11331\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"Suppl 1","key":"264_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2184.2008.00493.x","volume":"41","author":"S Yamanaka","year":"2008","unstructured":"Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif. 2008;41 Suppl 1:51\u20136.","journal-title":"Cell Prolif."},{"key":"264_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473:221\u20135.","journal-title":"Nature."},{"key":"264_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz J, Schreiber-Agus N, Li\u00e9geois NJ, Silverman A, Alland L, Chin L, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2\u2019s inhibition of p53. Cell. 1998;92:713\u201323.","journal-title":"Cell."},{"key":"264_CR38","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1167\/iovs.09-4504","volume":"51","author":"M Chen","year":"2010","unstructured":"Chen M, Chen Q, Sun X, Shen W, Liu B, Zhong X, et al. Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts. Invest Ophthalmol Vis Sci. 2010;51:5970\u20138.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"264_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0006-291X(02)02126-5","volume":"297","author":"X Zhao","year":"2002","unstructured":"Zhao X, Liu J, Ahmad I. Differentiation of embryonic stem cells into retinal neurons. Biochem Biophys Res Commun. 2002;297:177\u201384.","journal-title":"Biochem Biophys Res Commun."},{"key":"264_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbrc.2009.01.038","volume":"380","author":"B Jagatha","year":"2009","unstructured":"Jagatha B, Divya MS, Sanalkumar R, Indulekha CL, Vidyanand S, Divya TS, et al. In vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitors. Biochem Biophys Res Commun. 2009;380:230\u20135.","journal-title":"Biochem Biophys Res Commun."},{"key":"264_CR41","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1073\/pnas.0905245106","volume":"106","author":"JS Meyer","year":"2009","unstructured":"Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2009;106:16698\u2013703.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"264_CR42","doi-asserted-by":"publisher","first-page":"12769","DOI":"10.1073\/pnas.0601990103","volume":"103","author":"DA Lamba","year":"2006","unstructured":"Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103:12769\u201374.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"264_CR43","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1093\/emboj\/cdg291","volume":"22","author":"AA Sharov","year":"2003","unstructured":"Sharov AA, Weiner L, Sharova TY, Siebenhaar F, Atoyan R, Reginato AM, et al. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J. 2003;22:2992\u20133003.","journal-title":"EMBO J."},{"key":"264_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-4159.2012.07770.x","volume":"122","author":"V Corvino","year":"2012","unstructured":"Corvino V, Marchese E, Giannetti S, Lattanzi W, Bonvissuto D, Biamonte F, et al. The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J Neurochem. 2012;122:415\u201326.","journal-title":"J Neurochem."},{"key":"264_CR45","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/dvdy.20891","volume":"235","author":"RM Anderson","year":"2006","unstructured":"Anderson RM, Stottmann RW, Choi M, Klingensmith J. Endogenous bone morphogenetic protein antagonists regulate mammalian neural crest generation and survival. Dev Dyn. 2006;235:2507\u201320.","journal-title":"Dev Dyn."},{"key":"264_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1023\/A:1021825317546","volume":"22","author":"HF Carrer","year":"2002","unstructured":"Carrer HF, Cambiasso MJ. Sexual differentiation of the brain: genes, estrogen, and neurotrophic factors. Cell Mol Neurobiol. 2002;22:479\u2013500.","journal-title":"Cell Mol Neurobiol."},{"key":"264_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12031-012-9938-7","volume":"50","author":"Y Chen","year":"2013","unstructured":"Chen Y, Su Y, Run X, Sun Z, Wang T, Sun S. Pretreatment of PC12 cells with 17beta-estradiol prevents Abeta-induced down-regulation of CREB phosphorylation and prolongs inhibition of GSK-3beta. J Mol Neurosci. 2013;50:394\u2013401.","journal-title":"J Mol Neurosci."},{"key":"264_CR48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/dneu.20373","volume":"67","author":"X Zhou","year":"2007","unstructured":"Zhou X, Li F, Ge J, Sarkisian Jr SR, Tomita H, Zaharia A, et al. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol. 2007;67:603\u201316.","journal-title":"Dev Neurobiol."},{"key":"264_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/bjo.85.7.877","volume":"85","author":"C Munaut","year":"2001","unstructured":"Munaut C, Lambert V, No\u00ebl A, Frankenne F, Deprez M, Foidart JM, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol. 2001;85:877\u201382.","journal-title":"Br J Ophthalmol."},{"key":"264_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","volume":"126","author":"C Frezza","year":"2006","unstructured":"Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177\u201389.","journal-title":"Cell"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-015-0264-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0264-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:25:45Z","timestamp":1718299545000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-015-0264-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1186\/s13287-015-0264-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]},"assertion":[{"value":"17 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}